Share this article

According to GlobalData, SARS-COV-2 NGS ASSAY is one of 108 product lines sold in the US covid-19 tests market; these product lines are sold by 60 different manufacturers. The price of the SARS-COV-2 NGS ASSAY device can be viewed in GlobalData’s micro pricing report and can be retrieved according to purchase date, facility type, bed size, and geographical region. Buy the report here.

Smarter leaders trust GlobalData

The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches.

In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as Twist Bioscience apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets. In addition, sale location can also affect the final selling price of a device, both in terms of geographical region and facility type. Prices for the same medical device often vary in hospitals and health systems versus outside of hospital facilities, for example if high volume healthcare institutions can negotiate discounts or rebates based on large purchase sizes.

Twist Bioscience overview

Twist Bioscience Corp (Twist Bioscience) is a synthetic biology company that carries out the development of synthetic DNA and synthetic DNA-based products. The company offers synthetic genes and gene fragments, oligonucleotide, IgG proteins, next-generation sequencing (NGS) tools, drug and target discovery solutions, and synthetic viral controls, infectious disease research tools. Its products are used to treat influenzas, rhinoviruses, respiratory syncytial virus, SARS, MERS and coronaviruses, among others. Twist Bioscience’s silicon-based DNA synthesis platform enables the sequencing process and the production of synthetic DNA tools. The company serves health care, food and agriculture, industrial chemicals and materials, academic research and technology sectors. It sells products through distributors, direct sales personnel, commercial consultants. The company operates in China, Israel, China, Singapore and the US. Twist Bioscience is headquartered in South San Francisco, California, the US.

For a complete picture of SARS-COV-2 NGS ASSAY, COVID-19 Tests pricing in the US, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.